Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.83 USD | -8.02% | -2.27% | -12.37% |
04-12 | Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing | MT |
04-04 | Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing | MT |
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
Benjamin Dake
FOU | Founder | 48 | 26/07/18 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 31/01/21 |
George Eldridge
DFI | Director of Finance/CFO | 61 | 28/02/21 |
Marco Verwijs
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/22 |
Hunter Gillies
CTO | Chief Tech/Sci/R&D Officer | 58 | 30/04/20 |
Ralph Niven
CTO | Chief Tech/Sci/R&D Officer | 64 | 30/06/20 |
Timothy Pigot
PRN | Corporate Officer/Principal | - | 31/05/21 |
Sue Fischer
PRN | Corporate Officer/Principal | - | - |
Donna Dea
LAW | General Counsel | - | 31/08/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Santel
BRD | Director/Board Member | 62 | 18/01/23 |
Maha Katabi
BRD | Director/Board Member | 50 | 31/07/20 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 31/01/21 |
Dave Grayzel
BRD | Director/Board Member | 56 | 31/07/20 |
Mark Iwicki
BRD | Director/Board Member | 57 | 31/01/21 |
Joshua Resnick
BRD | Director/Board Member | 49 | 30/09/18 |
Allison Dorval
BRD | Director/Board Member | 48 | 14/07/21 |
Habib Dable
CHM | Chairman | 54 | 09/07/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,737,381 | 28,728,904 ( 99.97 %) | 0 | 99.97 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.37% | 570M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- AVTE Stock
- Company Aerovate Therapeutics, Inc.